: 185 significantly altered genes from IDC versus NAT comparison with 99 validated genes from our second cohort, as well as the 95 validated genes from the TCGA cohort. The 66 genes that are significantly different in all three cohorts are shown in bold. 28 genes are highlighted with * are TNBC specific genes validated in our second cohort, 14 genes highlighted with ^ are TNBC specific genes validated in the TCGA cohort. NS = "not significant" in the validation/TCGA cohort; NOA = "Not on Array" that was used for validation/TCGA cohort. 
Study cohort
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# of molecules shows the number of molecules in the pathway that are from our list of 185 significant genes A Consistency Score: higher scores mean networks are directionally consistent, meaning that most of the paths from regulator to target to disease/ function are consistent with the predicted state of the regulator, the observed direction of expression of the target in the dataset and the expected impact on the disease/function downstream, based on findings from the literature. # of molecules shows the number of molecules in the pathway that are from our list of 185 significant genes A Consistency Score: higher scores mean networks are directionally consistent, meaning that most of the paths from regulator to target to disease/ function are consistent with the predicted state of the regulator, the observed direction of expression of the target in the dataset and the expected impact on the disease/function downstream, based on findings from the literature. 
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